Prime Medicine (PRME) Non-Current Assets (2021 - 2026)

Prime Medicine (PRME) has 6 years of Non-Current Assets data on file, last reported at $156.8 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 4.6% year-over-year to $156.8 million; the trailing twelve-month figure through Mar 2026 stood at $629.6 million (up 47.92% YoY), and the FY2025 full-year result was $161.4 million, up 88.55% from the prior year.
• Non-Current Assets for Q1 2026 stood at $156.8 million, down from $161.4 million in the prior quarter.
• Across five years, Non-Current Assets topped out at $164.4 million in Q1 2025 and bottomed at $50.9 million in Q4 2023.
• The 5-year median for Non-Current Assets is $86.7 million (2024), against an average of $100.7 million.
• The widest annual swing landed in 2022, when Non-Current Assets soared 103.65%; it then fell 20.13% in 2023.
• A 5-year view of Non-Current Assets shows it stood at $63.7 million in 2022, then fell by 20.13% to $50.9 million in 2023, then surged by 68.3% to $85.6 million in 2024, then jumped by 88.55% to $161.4 million in 2025, then decreased by 2.85% to $156.8 million in 2026.
• The last three Non-Current Assets figures came in at $156.8 million (Q1 2026), $161.4 million (Q4 2025), and $153.6 million (Q3 2025), per Business Quant data.

Peer Comparison